|
Product Name: |
RU58841 |
|
Cas No.: |
154992-24-2 |
|
Standard: |
≥99% |
|
Molecular Formula: |
C17H18F3N3O3 |
|
Molecular Weight: |
369.341 |
|
Application: |
Only for R&D Purpose. |
|
Packing: |
10g,100g,1kg |
|
Remark: |
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer. |
Description
the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of RU58841 have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery. Recent years have seen the odd study pop up in relation to RU58841 and the treatment of acne and prostate cancer, which are conditions also driven by testosterone, however, the most recent study published in relation to RU58841 was back in 2008.
RU58841 is a non-steroidal anti-androgen drug, which competes with dihydrotestosterone or DHT for binding at the receptors where it causes hirsutism or hair loss. It has been evaluated as being approximately equivalent in strength to hydroxyflutamide, a drug which is sometimes used in PCOS to treat hirsutism or androgenetic alopecia. One study in 1998 concluded